Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Herbal Medicine

Background:

• Cardiovascular diseases (circulatory diseases) pose a significant global health threat due to high prevalence, disability, and mortality.
• Etiologies include hyperlipidemia, hypertension, atherosclerosis, and thickened blood, with incidence rates continuing to rise.
• Traditional Chinese Medicine offers potential therapeutic avenues for managing these conditions.

Purpose of the Study:

• To review the pharmacological effects of Rhodiola rosea on cardiovascular diseases.
• To explore the medicinal value of Rhodiola rosea's chemical components in treating circulatory diseases.
• To provide references for the clinical application of Rhodiola rosea in cardiovascular medicine.

Main Methods:

• Literature review of research on Rhodiola rosea and cardiovascular diseases.
• Analysis of studies detailing the pharmacological actions of Rhodiola rosea.
• Synthesis of information on chemical constituents and their cardiovascular benefits.

Main Results:

• Rhodiola rosea exhibits antimyocardial ischemia-reperfusion injury effects.
• It demonstrates efficacy in lowering blood fat, antithrombosis, and antiarrhythmia.
• Various chemical components contribute to its diverse pharmacological actions on cardiovascular health.

Conclusions:

• Rhodiola rosea possesses multiple beneficial pharmacological effects relevant to cardiovascular diseases.
• Its varied chemical constituents offer significant medicinal value for treating circulatory conditions.
• Further research supports Rhodiola rosea as a valuable reference for clinical cardiovascular disease treatment.